Qbiotics have almost singlehandedly engineered the breakthrough success of TT to date. But just consider the wording of virbac
Virbac announces the approval of Stelfonta® (tigilanol tiglate injection) We are delighted to announce that, through a collaboration with QBiotics, Virbac is providing veterinarians in the United States with a breakthrough injectable solution to treat mast cell tumors in dogs.
Reduced to collaborators as if beholden to giant multinationals, when its their discovery, hard work and perseverance and our investment that largely brought TT to market. Not Virbac, as they very clearly state. Wish they would show more gumption.
